PCRX
Pacira BioSciences, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
23.18
close · 2026-08-13
value
85
cheaper than peers85
quality
55
stronger fundamentals55
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 6.64× | 83 |
| price to book | 1.39× | 81 |
| price to sales | 1.34× | 79 |
| EV to EBITDA | 9.97× | 63 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 61.3% | 71 |
| return on equity | 2.0% | 59 |
| operating margin | 6.2% | 43 |
| revenue growth | 6.2% | 42 |
4 of 4 measures available
Facts
| market cap | $924M |
| free cash flow | $92.8M |
| employees | 825 |
| first trade | 2011-02-03 |
| next earnings | 2026-08-04 |
| fundamentals updated | 2026-08-07 |